Pharmaceutical composition containing 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid to treat a cyclooxygenase-2 dependent disorder

摘要

A solid pharmaceutical composition for treating a cyclooxygenase-2 dependent disorder or condition is disclosed, wherein the solid pharmaceutical composition comprises between about 200 and about 400 mg of 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid, wherein the residual moisture levels of said composition is between about 1.5% and about 5%.